Meta-analysis of MMP9 -1562C/T and the risk of coronary heart disease

Cardiology (Switzerland)

Volumn 124, Issue 1, 2013, Pages 53-59

  Li, Junyan ^a   Lu, Hao ^a   Tao, Feng ^a   Zhou, Hua ^a   Feng, GuoyYing ^b   He, Lin ^b   Zhou, Ligang ^a  

^a SHUGUANG HOSPITAL AFFILIATED TO SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Coronary heart disease; Genetic polymorphism; Matrix metalloproteinase 9; Meta analysis

Indexed keywords

GELATINASE B;

ALLELE; ARTICLE; CARDIOVASCULAR RISK; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; DATA BASE; ETHNIC GROUP; HEREDITY; META ANALYSIS (TOPIC); PUBLISHING;

CORONARY DISEASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MATRIX METALLOPROTEINASE 9; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84872277195     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000345772     Document Type: Article

References (43)

1. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, Dixon RJ, Meitinger T, Braund P, Wichmann HE, Barrett JH, Konig IR, Stevens SE, Szymczak S, Tregouet DA, Iles MM, Pahlke F, Pollard H, Lieb W, Cambien F, Fischer M, Ouwehand W, Blankenberg S, Balmforth AJ, Baessler A, Ball SG, Strom TM, Braenne I, Gieger C, Deloukas P, Tobin MD, Ziegler A, Thompson JR, Schunkert H: Genomewide association analysis of coronary artery disease. N Engl J Med 2007; 357: 443-453
2. Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, Hirayama H, Sone T, Tanaka M, Yokota M: Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002; 347: 1916-1923
3. Wu N, Lu X, Hua Y, Song L, Ye J, Li J, Meng X, Gu D, Yang Y: Haplotype analysis of the stromelysin-1 (MMP3) and gelatinase B (MMP9) genes in relation to coronary heart disease. Ann Hum Genet 2009; 73: 404-410
4. Alp E, Menevse S, Tulmac M, Kan D, Yalcin R, Erkan AF, Cengel A: Lack of association between matrix metalloproteinase-9 and endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in Turkish population. DNA Cell Biol 2009; 28: 343-350
5. Koh YS, Chang K, Kim PJ, Seung KB, Baek SH, Shin WS, Lim SH, Kim JH, Choi KB: A close relationship between functional polymorphism in the promoter region of matrix metalloproteinase-9 and acute myocardial infarction. Int J Cardiol 2008; 127: 430-432
6. Wang L, Zhu T, Li Y: Relationship between matrix metalloproteinase-9 polymorphism and acute coronary syndrome. J Nanjing Med Univ 2007; 21: 147-150
7. Horne BD, Camp NJ, Carlquist JF, Muhlestein JB, Kolek MJ, Nicholas ZP, Anderson JL: Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease. Am Heart J 2007; 154: 751-758
8. Wang L, Ma YT, Xie X, Yang YN, Fu ZY, Liu F, Li XM, Chen BD: Association of MMP9 gene-1562 C/T polymorphism with myocardial infarction in Uighur population of Xinjiang (in Chinese). Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2011; 28: 180-184
9. Kaplan RC, Smith NL, Zucker S, Heckbert SR, Rice K, Psaty BM: Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke. Atherosclerosis 2008; 201: 130-137
10. Abilleira S, Bevan S, Markus HS: The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis. J Med Genet 2006; 43: 897-901
11. Medley TL, Cole TJ, Dart AM, Gatzka CD, Kingwell BA: Matrix metalloproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression. Arterioscler Thromb Vasc Biol 2004; 24: 1479-1484
12. Zhang B, Ye S, Herrmann SM, Eriksson P, de Maat M, Evans A, Arveiler D, Luc G, Cambien F, Hamsten A, Watkins H, Henney AM: Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 1999; 99: 1788-1794
13. Zhi H, Wang H, Ren L, Shi Z, Peng H, Cui L, Ma G, Ye X, Feng Y, Shen C, Zhai X, Zhang C, Zen K, Liu N: Functional polymorphisms of matrix metallopeptidase-9 and risk of coronary artery disease in a Chinese population. Mol Biol Rep 2010; 37: 13-20
14. Jefferis BJ, Whincup P, Welsh P, Wannamethee G, Rumley A, Lennon L, Thomson A, Lawlor D, Carson C, Ebrahim S, Lowe G: Prospective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women. Atherosclerosis 2010; 208: 557-563
15. Galis ZS, Khatri JJ: Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly. Circ Res 2002; 90: 251-262
16. Loftus IM, Naylor AR, Goodall S, Crowther M, Jones L, Bell PR, Thompson MM: Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke 2000; 31: 40-47
17. Galis ZS, Sukhova GK, Lark MW, Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994; 94: 2493-2503
18. Goracy J, Goracy I, Brykczynski M, Peregud-Pogorzelska M, Naruszewicz M, Ciechanowicz A: The C(-1562)T polymorphism in the promoter of the matrix metalloproteinase-9 (MMP-9) gene and coronary atherosclerosis (in Polish). Pol Arch Med Wewn 2003; 110: 1275-1281
19. Luttun A, Dewerchin M, Collen D, Carmeliet P: The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke: Insights from genetic studies. Curr Atheroscler Rep 2000; 2: 407-416
20. Wang J, Warzecha D, Wilcken D, Wang XL: Polymorphism in the gelatinase B gene and the severity of coronary arterial stenosis. Clin Sci (Lond) 2001; 101: 87-92
21. Henney AM, Ye S, Zhang B, Jormsjo S, Whatling C, Eriksson P, Hamsten A: Genetic diversity in the matrix metalloproteinase family. Effects on function and disease progression. Ann NY Acad Sci 2000; 902: 27-37, discussion 37-28
22. Kim JS, Park HY, Kwon JH, Im EK, Choi DH, Jang YS, Cho SY: The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina. Yonsei Med J 2002; 43: 473-481
23. Morgan AR, Zhang B, Tapper W, Collins A, Ye S: Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease. J Mol Med (Berl) 2003; 81: 321-326
24. Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G, Meyer J, Cambien F, Tiret L: Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 2003; 107: 1579-1585
25. Kelly D, Khan SQ, Thompson M, Cockerill G, Ng LL, Samani N, Squire IB: Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: Novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction. Eur Heart J 2008; 29: 2116-2124
26. DerSimonian R, Laird N: Meta-Analysis in clinical trials. Control Clin Trials 1986; 7: 177-188
27. Zintzaras E, Hadjigeorgiou GM: Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: A meta-Analysis. J Hum Genet 2004; 49: 474-481
28. Mantel N, Bohidar NR, Ciminera JL: Mantel-Haenszel analyses of litter-matched timeto-response data, with modifications for recovery of interlitter information. Cancer Res 1977; 37: 3863-3868
29. Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-Analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634
30. Cho HJ, Chae IH, Park KW, Ju JR, Oh S, Lee MM, Park YB: Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis after percutaneous coronary intervention. J Hum Genet 2002; 47: 88-91
31. Fallah S, Seifi M, Ghasemi A, Firoozrai M, Samadikuchaksaraei A: Matrix metalloproteinase-9 and paraoxonase 1 Q/R192 gene polymorphisms and the risk of coronary artery stenosis in Iranian subjects. J Clin Lab Anal 2010; 24: 305-310
32. Haberbosch W, Gardemann A: Gelatinase B C(-1562)T polymorphism in relation to ischaemic heart disease. Scand J Clin Lab Invest 2005; 65: 513-522
33. Nanni S, Melandri G, Hanemaaijer R, Cervi V, Tomasi L, Altimari A, Tricoci P, Melloni C, Branzi A: Matrix metalloproteinase genetic polymorphisms in premature coronary artery disease. J Am Coll Cardiol 2003; 41: 234
34. Nuzzo D, Vasto S, Balistreri CR, Di-Carlo D, Listi F, Caimi G, Caruso M, Hoffmann E, Incalcaterra E, Lio D, Caruso C, Candore G: Role of proinflammatory alleles in longevity and atherosclerosis: Results of studies performed on-1562C/T MMP-9 in centenarians and myocardial infarction patients from Sicily. Ann NY Acad Sci 2006; 1089: 496-501
35. Wang L, Ma YT, Xie X, Yang YN, Fu ZY, Li XM, Liu F, Huang Y, Ma X, Chen BD, Yuan S, Sun MH, Peng X, Wang BZ: Interaction between MMP-9 gene polymorphisms and smoking in relation to myocardial infarction in a Uighur population. Clin Appl Thromb Hemost 2012; 18: 72-78
36. Wu S, Hsu LA, Teng MS, Lin JF, Chang HH, Chang PY, Hu CF, Ko YL: Association of matrix metalloproteinase 9 genotypes and cardiovascular disease risk factors with serum matrix metalloproteinase 9 concentrations in Taiwanese individuals. Clin Chem Lab Med 2010; 48: 543-549
37. Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM: Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation 1995; 91: 2125-2131
38. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI: SV40-Transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 1989; 264: 17213-17221
39. Hibbs MS, Hoidal JR, Kang AH: Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. J Clin Invest 1987; 80: 1644-1650
40. Zhang B, Henney A, Eriksson P, Hamsten A, Watkins H, Ye S: Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1. Hum Genet 1999; 105: 418-423
41. Allan JA, Docherty AJ, Barker PJ, Huskisson NS, Reynolds JJ, Murphy G: Binding of gelatinases A and B to type-I collagen and other matrix components. Biochem J 1995; 309: 299-306
42. O'Farrell TJ, Pourmotabbed T: Identification of structural elements important for matrix metalloproteinase type V collagenolytic activity as revealed by chimeric enzymes. Role of fibronectin-Like domain and active site of gelatinase B. J Biol Chem 2000; 275: 27964-27972
43. Coronary Artery Disease (C4D) Genetics Consortium: A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet 2011; 43: 339-344